semaglutide - Page 5 of 5 - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Infographic showing EPACK Prefab Technologies Limited’s ₹100 crore Ghiloth manufacturing facility in Rajasthan, highlighting commercial production, expanded pre-engineered building and insulated-panel capacity, and existing panel utilisation of 49.5%.

EPACK Prefab Technologies expands Rajasthan manufacturing capacity with Rs 1,376cr order book, but margins remain under pressure

Infographic showing Molecular Partners’ plan to cut up to 55 jobs, or about 44% of its workforce, while refocusing on targeted radiotherapy and lead Radio-DARPin candidate MP0712 ahead of expected efficacy data in 2027.

Molecular Partners (NASDAQ: MOLN) plans 44% workforce cut as MP0712 becomes central to strategy

Australia budget update faces fresh pressure as inflation hits 4.3%

Evolution Mining’s Carnaby acquisition nears completion as A$22m Glencore share settlement advances

Read More

Pharma Industry News

Biocon and Biomm ink exclusive deal to bring Semaglutide to Brazil

Biocon Limited (BSE code: 532523, NSE: BIOCON), a leader in global biopharmaceutical innovations, has announced a pivotal licensing…

byPallavi Madhiraju

April 17, 2024

Lilly completes $1.9bn acquisition of Versanis Bio

Read More

Pharma Industry News

Lilly expands portfolio with $1.9bn acquisition of Versanis Bio

In a move marking a significant expansion in the biopharmaceutical sector, Eli Lilly and Company (Lilly) has successfully…

byPallavi Madhiraju

August 15, 2023

Lilly set to purchase Versanis Bio in potential $1.9bn deal

Read More

Pharma Industry News

Lilly to acquire clinical-stage biopharma company Versanis Bio

American pharma giant Eli Lilly and Company (Lilly) and Versanis Bio have announced a definitive agreement in which…

byPallavi Madhiraju

July 14, 2023

web analytics